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Introduction
QRS complex refers to the combination of three of the graphical deflections seen on a typical electrocardiogram (ECG). QRS dispersion is defined as the difference between the maximum and minimum QRS duration measured in the standard twelve lead ECG. It has been suggested that an increased QRS dispersion (QRSd) is a marker of inhomogeneous ventricular depolarization and could be associated with negative prognosis (1) .
Dispersion of surface ECG wave durations or intervals (P wave, QRS, QT interval, JT interval) has been assiduously studied in the search for non-invasive cardiac markers useful in predicting the risk of atrial fibrillation, ventricular arrhythmia, and sudden cardiac death, and also as nonspecific prognosis markers. The largest body of data refers to QT dispersion (QTd), but, after an initial flurry of positive results, the potential significance of QT dispersion slowly entered into obscurity, due to a number of fundamental issues (2) .
The most important criticism is based on the way the ECG is constructed and derived from the projection of the electrical activity loops. It has been suggested that, at least in limb leads, QT-d is an 'illusion'. Other methodological issues in QT dispersion are associated with its poor reproducibility, mostly due to the difficulty of identifying T wave offset. Some authors have extended the same arguments to P wave dispersion (3), but the question arises as to whether they also affect QRS dispersion.
As Batchvarov stated (4) ''the clinical significance of an ECG marker should be proved or disproved on the basis of its reproducibility and its link to important clinical events or other clinical variables (or lack thereof). Attempts to bolster its clinical significance by speculating about underlying electrophysiological mechanism (for example in manuscripts reporting purely clinical ECG studies) should be discouraged''.
In this paper, we review studies supporting the need for continued research into QRSd and argue that abandoning its potential utility should not occur just because of insufficient knowledge regarding its electrophysiological basis.
Discussion

Does QRS dispersion have an electrophysiological basis? Differences in excitation times of the normal human heart
Durrer et al., as early as in 1970, reviewed several studies and considered: ''knowledge of the time course and instantaneous distribution of the excitatory process of the normal human heart would be of value for understanding the QRS complex'' (5).
They studied seven re-perfused normal human hearts which were removed within half an hour after death.
Electrocardiograms taken before death were not suggestive of heart disease. The hearts were maintained under physiological conditions for conducting the study, 
QRS dispersion in myocardial infarction patients
Perkiömäki and colleagues studied a set of 100 patients: 30 healthy subjects, 40 patients with a history of myocardial infarction (MI), without arrhythmic events or inducible ventricular tachycardia (VT) at electrophysiological study (EPS), and 30 patients with prior MI and history of cardiac arrest (12 patients) or VT (18 subjects) and inducible monomorphic VT at electrophysiological study (8) . Although the focus was QT dispersion (QTd), QRSd was also measured. QRS dispersion was 28 ± 11 ms in the normal group, 46 ± 13 ms in the group with MI and no VT, and 48 ± 16 ms in the group with MI and VT (p < 0.001 between patients without VT vs. healthy subjects and between patients with VT vs. healthy subjects). The maximal and minimal QRS duration were also higher in patients with prior MI compared to healthy subjects (p < 0.001).
A more extensive study which included 724 patients (9) showed that increased QRS duration (> 110 ms) or dispersion was not correlated with arrhythmic events, and also QRS dispersion was not correlated with death during follow-up.
The effect of therapy of acute MI on QRSd was analyzed mostly indirectly in studies with other main targets. Moreno et al., in a pre-primary PCI era study, analyzed the effect of thrombolysis on QTd and QRSd (10). They included 244 patients with AMI treated with streptokinase or anistreplase. Dispersion of QT, JT, and QRS were measured at 9 ± 5 days after thrombolytic therapy by using a computerized method. The maximal QRS interval was 93 ± 11 ms and was observed in a precordial lead in 56% of patients and from one of the limb leads in 44%. The minimal QRS interval was 68 ± 10 ms and was noticed in a precordial lead in 39% of patients and in limb leads in 61%. The average QRSd was 24 ± 9 milliseconds (range: 6 -58 ms). QRSd was not correlated with the perfusion grade observed at coronary angiography (25 ± 10 ms in grade TIMI 0, 22 ± 7 ms in grade TIMI 1, 28 ± 9 ms in grade TIMI 2, and 24 ± 9 ms in grade TIMI 3; p = 0.24).
Mozos studied 16 patients (13 men, 3 women) with prior MI (occurring at least one year prior), searching for correlations between signal-averaged late ventricular potentials (LVP) and 12-lead ECG dispersion indices (QRS, QT and JT intervals) (11). Patients with hypokalemia, hypocalcemia, or hypomagnesaemia and those not in sinus rhythm were excluded. There were 6 patients in class III NYHA heart failure. QRS dispersion was measured manually using at least 8 leads for each patient.
The following parameters regarding depolarization were calculated: QRS dispersion (QRSd), QRSdc (heart rate corrected QRSd), QRScmax (heart rate corrected maximum QRS duration) and QRScmin Other indices had weak correlations. Given the small number of patients, the significance of the results to the larger population remains unclear.
QRD dispersion in heart failure
Anastasiou-Nana et al. followed 104 class II-IV NYHA heart failure patients with systolic dysfunction (left ventricular ejection fraction < 35%) for 20 ± 12 months, with cardiac death as the end-point (12 (measured by magnetic resonance imaging) (13).
Cardiac mortality was higher in patients with both abnormal QRSd (> 25 ms) and QTcd (> 62 ms), with better positive predictive value than in those with just one abnormal parameter (63% vs 15%, p = 0.01).
QRS dispersion was incorporated into a prognostic index assessing the long-term mortality of 553 patients with class I-III NYHA heart failure from the UK-HEART study (14) . Mean QRSd was 44.6 ± 15. 37.14 ± 13.8 ms; p=0.04) and decreased after resynchronization, especially in responders. There was a linear correlation between LVEF and QRSd (r=0.34, p=0.02 at six months follow-up). Considering this research, the same group proposes that besides duration, QRS dispersion should be measured in future investigations about resynchronization therapy, in order to reach better predicting indexes for such electrical therapy (20) . 
QRS dispersion in cardiomyopathies
